Pharmaids Pharmaceuticals Ltd

Pharmaids Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Pharmaids Pharmaceuticals Ltd

₹ 30.1 -1.70%
15 May - close price
pharmaids.com BSE: 524572
About

Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services.
It is undergoing a business transition and aims to build a CRDMO platform.[1]

Key Points

Business Overview[1]
The company is engaged in research, development, and manufacturing services.
It is pursuing organic and inorganic growth opportunities and is in the process of a business transition, including strengthening its leadership team. It is working towards establishing a Contract Research, Development, and Manufacturing Organization (CRDMO) to offer integrated services across pharma, biopharma, agrochemicals, medical devices, and specialty chemicals for domestic and international markets.

Website BSE
  • Market Cap ₹ 106 Cr.
  • Current Price ₹ 30.1
  • High / Low ₹ 73.4 / 27.1
  • Stock P/E
  • Book Value ₹ 16.4
  • Dividend Yield 0.00 %
  • ROCE -6.87 %
  • ROE -10.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 33.0%
  • Company has a low return on equity of -15.3% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
0.00 0.00 0.00 0.00 0.02 0.01 0.17 0.83 1.21 0.13 1.12 5.97 0.83
0.69 8.60 1.61 1.02 2.45 1.81 1.89 1.97 2.94 2.82 6.00 10.55 4.50
Operating Profit -0.69 -8.60 -1.61 -1.02 -2.43 -1.80 -1.72 -1.14 -1.73 -2.69 -4.88 -4.58 -3.67
OPM % -12,150.00% -18,000.00% -1,011.76% -137.35% -142.98% -2,069.23% -435.71% -76.72% -442.17%
0.00 0.00 0.41 -0.26 0.76 0.03 0.00 0.01 0.00 1.01 0.35 3.32 0.06
Interest 0.00 0.00 0.00 0.00 0.02 0.29 0.01 0.01 0.07 2.05 1.11 1.02 0.57
Depreciation 0.01 0.00 0.01 0.01 0.04 0.05 0.05 0.05 0.05 0.05 0.05 0.06 0.05
Profit before tax -0.70 -8.60 -1.21 -1.29 -1.73 -2.11 -1.78 -1.19 -1.85 -3.78 -5.69 -2.34 -4.23
Tax % 0.00% -28.37% 7.44% -60.47% -33.53% 6.16% -8.43% -15.13% -13.51% -19.05% -23.37% -29.06% -26.71%
-0.71 -6.16 -1.30 -0.50 -1.15 -2.24 -1.62 -1.01 -1.59 -3.06 -4.36 -1.65 -3.11
EPS in Rs -0.54 -2.87 -0.61 -0.23 -0.54 -0.64 -0.46 -0.29 -0.45 -0.87 -1.24 -0.47 -0.88
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
1 2 2 1 0 1 0 9 4 0 0 2 8
2 2 2 2 1 1 0 8 4 10 6 10 24
Operating Profit -0 -0 -0 -0 -0 -0 -0 0 0 -10 -6 -7 -16
OPM % -32% -5% -21% -28% -87% -20% 1% 3% -21,267% -310% -197%
0 0 0 1 0 0 0 0 0 0 1 1 5
Interest 0 0 0 0 0 0 0 0 0 0 0 2 5
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax -0 -0 -0 0 -0 -0 -0 0 0 -10 -6 -9 -16
Tax % -3% -36% -7% -33% 5% 20% -108% 0% 0% -24% -19% -15%
-0 -0 -0 0 -0 -0 0 0 0 -8 -5 -7 -12
EPS in Rs -1.03 -0.21 -1.17 0.32 -1.15 -0.53 0.03 0.09 0.15 -3.52 -1.40 -2.06 -3.46
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 3%
5 Years: %
3 Years: -16%
TTM: 263%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -137%
Stock Price CAGR
10 Years: 26%
5 Years: 1%
3 Years: 0%
1 Year: -55%
Return on Equity
10 Years: -13%
5 Years: -13%
3 Years: -15%
Last Year: -11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 3 3 3 3 3 10 10 10 10 21 35 35 35
Reserves -2 -2 -2 -2 -2 -2 -2 -2 -2 1 36 29 23
0 0 0 0 0 0 0 0 0 0 13 40 18
1 1 1 1 0 0 0 1 2 2 1 15 21
Total Liabilities 3 3 2 2 1 9 8 9 11 25 85 119 97
1 0 0 0 0 0 0 0 0 0 17 24 8
CWIP 0 0 0 0 0 0 0 0 0 2 2 4 3
Investments 0 0 0 0 0 0 0 0 0 3 53 53 53
2 2 2 2 1 8 8 9 11 19 14 38 33
Total Assets 3 3 2 2 1 9 8 9 11 25 85 119 97

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 0 0 0 -0 -0 -1 0 -0 -4 -3 -8
0 -0 -0 0 -0 0 1 -0 0 -5 -73 -19
-0 -0 0 -0 -0 -0 0 0 0 21 66 25
Net Cash Flow -0 0 -0 0 -0 -0 -0 0 0 12 -10 -2
Free Cash Flow 0 0 -0 1 -0 -0 -1 0 -0 -6 -20 -17
CFO/OP -18% -233% -6% -97% 49% 91% 221% 410% -200% 41% 54% 106%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 331 234 232 240 422 580 12 124 0 25
Inventory Days 104 103 91 131 0 0 17 91 0 4,198 1,774
Days Payable 197 145 138 245 22 236 0 2,067
Cash Conversion Cycle 238 192 185 126 422 580 6 -21 4,198 -267
Working Capital Days 244 181 148 161 227 2,653 3 -18 14,600 -471
ROCE % -15% -5% -21% -24% -30% -3% -5% 1% 2% -64% -11% -7%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Capital Work-in-Progress (Standalone)
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Electricity Consumption
Units (KWH)
Number of Permanent Employees
Number
Land Assets (Manufacturing/R&D)
Acres
GLP Certified Research Facilities
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
9.94% 9.70% 9.25% 5.64% 5.56% 5.19% 5.22% 5.22% 5.14% 32.99% 32.99% 32.99%
90.07% 90.31% 90.75% 94.36% 94.44% 94.81% 94.79% 94.78% 94.87% 67.00% 67.01% 67.00%
No. of Shareholders 7,4767,3937,2817,5677,5948,0498,3498,2208,0268,0278,2888,406

Documents

Announcements

Annual reports